- Home
- MYGN vs LKFN Comparison
MYGN vs LKFN Comparison
Compare MYGN & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- LKFN
- Stock Information
- Founded
- MYGN 1991
- LKFN 1872
- Country
- MYGN United States
- LKFN United States
- Employees
- MYGN N/A
- LKFN N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LKFN Major Banks
- Sector
- MYGN Health Care
- LKFN Finance
- Exchange
- MYGN Nasdaq
- LKFN Nasdaq
- Market Cap
- MYGN 2.0B
- LKFN 1.7B
- IPO Year
- MYGN 1995
- LKFN 1997
- Fundamental
- Price
- MYGN $15.25
- LKFN $73.22
- Analyst Decision
- MYGN Buy
- LKFN Hold
- Analyst Count
- MYGN 12
- LKFN 3
- Target Price
- MYGN $27.64
- LKFN $71.00
- AVG Volume (30 Days)
- MYGN 990.7K
- LKFN 127.6K
- Earning Date
- MYGN 11-07-2024
- LKFN 10-25-2024
- Dividend Yield
- MYGN N/A
- LKFN 2.62%
- EPS Growth
- MYGN N/A
- LKFN 9.99
- EPS
- MYGN N/A
- LKFN 3.85
- Revenue
- MYGN $823,600,000.00
- LKFN $242,401,000.00
- Revenue This Year
- MYGN $13.85
- LKFN N/A
- Revenue Next Year
- MYGN $7.73
- LKFN $1.35
- P/E Ratio
- MYGN N/A
- LKFN $19.02
- Revenue Growth
- MYGN 12.15
- LKFN 3.62
- 52 Week Low
- MYGN $15.18
- LKFN $53.97
- 52 Week High
- MYGN $29.30
- LKFN $78.31
- Technical
- Relative Strength Index (RSI)
- MYGN 16.18
- LKFN 60.86
- Support Level
- MYGN $16.86
- LKFN $63.48
- Resistance Level
- MYGN $19.60
- LKFN $77.20
- Average True Range (ATR)
- MYGN 1.17
- LKFN 2.56
- MACD
- MYGN -0.25
- LKFN 0.64
- Stochastic Oscillator
- MYGN 0.90
- LKFN 65.68
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About LKFN Lakeland Financial Corporation
Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. Lakeland offers a broad range of products and services throughout its Northern and Central Indiana markets. The company offers commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.